At EASD 2023 in Hamburg, Professor Hugh Jones presents an analysis from the ABCD audit of Testosterone in Men with Type 2 Diabetes, confirming that testosterone replacement therapy does improve glycaemic control. Furthermore, the data showed that HbA1c continues to decrease over time. This was...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.